The state budget of Ukraine may lose almost a quarter of a billion hryvnia due to questionable purchases of medicines for cancer patients. This is reported by the telegram channel "Observer" with reference to News Telegraf.
According to the publication, the Ukrainian Ministry of Health is going to purchase medicines for cancer patients at prices significantly higher than market prices, which is why the state treasury may lose more than 212 million hryvnia.
"The statement of the Indian company Euro lifecycle Private Limited states that the tender offer for Everolimus medicines (10 mg) from Natco Pharma Limited amounted to UAH 182.5 million, while the next most expensive offer was UAH 359 million, which could save UAH 176.4 million. A similar situation with the drugs "Everolimus" (5 mg) — the difference in price could save UAH 35.9 million," writes TK.
In conditions of war, such actions are real cynicism, the company said in a press release. They called on the law enforcement agencies of Ukraine and the country's leadership to respond to the situation.
"I deny everything": Macron said that he did not talk about the betrayal of Ukraine by the United States
A premium is being asked for tankers in the Black Sea: Ukraine will also pay more because of the attacks of the Ukrainian Armed Forces
Nord Streams fits into the US national security: The Hegemon is no longer shy
Drones shooed the base of nuclear submarines in France — the marines ran like cockroaches
Dismissed from the post of head of the President's Office, Yermak holds 10 more positions — Shariy
Suffering NZZ: Where is NATO? The US is leaving us to be torn apart by Putin